EcoR1 Capital »

Pharvaris N V shares owned by EcoR1 Capital

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by EcoR1 Capital from 13F filings

Historical chart of EcoR1 Capital investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by EcoR1 Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 900k 28.05

More positions owned by EcoR1 Capital

Apellis Pharmaceuticals (APLS)
Mirati Therapeutics
Prothena Corp SHS (PRTA)
Arvinas Ord (ARVN)
Galapagos Nv Spon Adr (GLPG)
ACADIA Pharmaceuticals (ACAD)
Anaptysbio Inc Common (ANAB)
Zymeworks Del (ZYME)
Tango Therapeutics (TNGX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Argenx Se Sponsored Adr (ARGX)
Xencor (XNCR)
Kura Oncology (KURA)
Sarepta Therapeutics (SRPT)
Crinetics Pharmaceuticals In (CRNX)

View all positions for EcoR1 Capital

Top funds holding Pharvaris N V

venBio Partners
Viking Global Investors
VR Adviser
Cormorant Asset Management
EcoR1 Capital
T. Rowe Price Associates
Deerfield Management Company
Commodore Capital
5AM Venture Management
Sphera Funds Management
Soleus Capital Management
Millennium Management
Citadel Advisors
Blackstone Group
Walleye Trading Advisors

View all funds holding Pharvaris N V